Free press releases distribution network?

Agency / Source: ECON Corporate Services / InvestorIdeas.com™

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



MDM Group Joins Russian Biotechnological Consortium for Medicine and Agriculture - MDM to work with BIOMAC to develop Russian Technologies for use in the MDM Biodefense initiative
MDM Group Joins Russian Biotechnological Consortium for Medicine and Agriculture

 

PRZOOM - /newswire/ - Santa Clara, CA, United States, 2005/07/12 - MDM to work with BIOMAC to develop Russian Technologies for use in the MDM Biodefense initiative.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

MDM Group, Inc. (OTC.PK: MDDM) advises that it has signed an agreement to participate in the Russian Biotechnological Consortium for Medicine and Agriculture (BIOMAC). BIOMAC will use its resources as an interdepartmental instrument of the Russian government-private partnerships to locate technologies from throughout Russia. Further, BIOMAC will also be an advocate for technology transfer.

Consortium BIOMAC was formed in 2001 within the framework of the Agreement between four ministries of the Russian Federation: Ministries of Industry, Science and Technology, Ministry of Health, Ministry of Agriculture, and the Ministry of Education. Since inception, BIOMAC has been expanded to include the Russian Academies of Sciences, of Medical Sciences, and of Agricultural Sciences.

Under the Consortium BIOMAC memorandum:

BIOMAC will assist MDM in locating novel drugs, vaccines, diagnostics, and related technologies that directly apply to MDM's Biodefense Development undertakings; and,

BIOMAC will assist in the area of technology transfer as it relates to the Russian government.

Since MDM's November 10, 2004, announcement of the establishment of its Biodefense Division, MDM's team has been evaluating several technology opportunities from sources around the world. Consistent with its original mandate, MDM's focus is on niche projects in Defense or Homeland Security that have confirmed markets and can progress rapidly to products for countermeasure enhancement.

Dr. Ed Stephen, head of MDM's biodefense division, recently completed a one-month trip to Russia where he visited numerous partner research institutes and discussed many potential projects for MDM's Biodefense Development. Dr. Stephen commented, "Our ISTC Partnership, primarily involving former defense institutes, and now our membership in the Consortium for Medicine and Agriculture creates an immediate and important extension to the scientific capabilities and the facilities available to us. MDM has signed multiple NDAs and is now in the process of signing agreements for technologies that it will pursue in the short-term."

MDM Group is a development stage Company focused on the Security, Biodefense, Law Enforcement and Homeland Security industries.

Safe Harbor Statement

The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.

MDM Group is featured on Homelanddefensestocks.com a global investment research portal for defense and security.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: ECON Corporate Services / InvestorIdeas.com™

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


MDM Group Joins Russian Biotechnological Consortium for Medicine and Agriculture

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Anne Hoversten 
866-894-3910
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ECON Corporate Services / InvestorIdeas.com™ securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From ECON Corporate Services / InvestorIdeas.com™ / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today